(Q63401553)
Statements
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation (English)
0 references
13 July 2018
0 references
24 April 2021
0 references
484
0 references
12 year
0 references